Genetic Susceptibility to Breast and Ovarian Cancer
Publisher: American College of Medical Genetics 1999
Number of pages: 236
The Guidelines have been prepared to help the primary care provider to participate in the pre- and post-test education and counseling required for every patient contemplating genetic testing for breast and ovarian cancer. Although some important genetic, epidemiological, and clinical issues remain unresolved, it is essential that all health care providers understand the familial basis of some cancers and the potential applications of genetic testing as part of the risk assessment process.
Home page url
Download or read it online for free here:
by Paul J. Grippo, Hidayatullah G. Munshi - Transworld Research Network
Pancreatic adenocarcinoma is histologically characterized by a dense desmoplastic reaction surrounding malignant epithelial cells. The DR is composed of ECM proteins, fibroblasts, stellate cells, endothelial cells, immune cells, and neurons.
- Royal College of General Practitioners
The guideline covers twelve groups of cancers: lung, upper gastrointestinal cancers, lower gastrointestinal cancers, breast cancer, gynaecological cancers, urological cancers, haematological cancers, skin cancers, head and neck cancers, etc.
by Nancy E. Adler, Ann E. K. Page - National Academies Press
Today, it is not possible to deliver high-quality cancer care without using existing approaches, tools, and resources to address patients' psychosocial health needs. This book recommends actions to ensure that this standard is met.
- National Collaborating Centre for Cancer
These clinical guidelines review a number of clinical questions that involve the detection, diagnosis and initial management of ovarian cancer and which focus on areas of uncertainty or where there is a wide variation in clinical practice.